Postmenopausal women with early rheumatoid arthritis have a metabolic syndrome profile similar to men and should equally be considered high risk for the development of cardiovascular disease, according to Bindee Kuriya M.D, writing in the journal ACR Open Rheumatology.
Taking calcium supplements doesn't appear to worsen cardiovascular health in healthy postmenopausal women, according to a study presented at the American Society for Bone and Mineral Research annual meeting that took place over the weekend.
Levels of the biomarker urine C-telopeptide of cross-linked collagen type II (uCTX-II) are independently associated with radiographic severity and pain intensity in knee osteoarthritis, say researchers writing in Arthritis Research & Therapy this month.
Women with rheumatoid arthritis are concerned with pregnancy and parenting issues and require more information from their doctors, say researchers writing in ACR Open Rheumatology this month.
Fibromyalgia and polymyalgia rheumatica are distinctly different, but in a case report described in the May 8 issue of the American Journal of Case Reports, Fawad Aslam, M.D., of Mayo Clinic in Arizona, and colleagues describe a confusing case of a 30-year-old woman.
Women who have primary Sjögren’s Syndrome also have decreased lifetime exposure to estrogen, a new study has determined.
Women who have primary Sjögren’s Syndrome also have decreased lifetime exposure to estrogen, a new study finds.
Children born to women who have rheumatoid arthritis during pregnancy could experience life-long health effects due to changes to DNA that alter genetic activity, new research indicates.
Fatigue in patients with systemic lupus erythematosus (SLE) has been linked to anti-NR2 antibodies, which responds to treatment with belimumab, a study shows.
Our Top Stories in Rheumatology: Daily tofacitinib, pregnancy outcomes, pediatric lupus, RA risk and more
In this slideshow, we highlight the news you may have missed: Prescribing information for a newly approved treatment for pediatric lupus, new reports on negative pregnancy outcomes in PsA and ankylosing spondylitis, new information on the benefits of daily tofacitinib, and much more.